FDA Panel Backs 2 Hepatitis C Drugs
A major advance for treating hepatitis C is likely headed to market after government advisors backed two new drugs: telaprevir and boceprivir.
Click here to read the full story.
The content has been reported and it will be reviewed by a moderator.
